NS Pharma is working to have an important impact on the lives of patients with rare diseases. Our therapeutic areas encompass neurological diseases and inflammatory diseases.
Harnessing the power of innovative science can help bring new treatments to patients with rare diseases. NS Pharma is developing therapies through exon-skipping, cell therapy and JAK1 inhibition technology.
NS Pharma is working to have an important impact on the lives of patients with rare diseases. Our therapeutic areas encompass neurological diseases and inflammatory diseases.
Harnessing the power of innovative science can help bring new treatments to patients with rare diseases. NS Pharma is developing therapies through exon-skipping, cell therapy and JAK1 inhibition technology.
Press Release / July 1, 2025
NS Pharma Announces Strategic Alliance with Boston Children’s Hospital to Develop New Therapies for Rare Diseases
Starting tomorrow, Team Joseph kicks off the second annual What Now Conference!
It's a FREE and 100% virtual event created by and for older teens and adults living with Duchenne.
Register now to get involved: https://ow.ly/3NGC50Wp4Uw
#Duchenne #RareDiseases #VirtualConference https://x.com/NSPharmaInc/status/1945121807947747579/photo/1
Recently, NSP team members Patti Santiago and Latoya Martin had the privilege of spending time with one of the incredible campers at #CampPromise!
A huge thank you to the @JettFoundation for building a space filled with joy, laughter and inclusion. 💙
#Duchenne #RareDisease https://x.com/NSPharmaInc/status/1945121171072278859/photo/1
Are there ways to increase levels of dystrophin?🧬
Yes - #ExonSkipping and #GeneTherapy!
Both approaches aim to improve muscle function and slow progression.
Learn more about these options and how they work by visiting: https://ow.ly/wWxc50Wiiyc
#DuchenneAwareness https://x.com/NSPharmaInc/status/1943671824597778906/photo/1
Say hello to Jodie Danko, our new Senior Director of #PatientServices!🌟
With 20+ years of experience in the industry, Jodie brings deep expertise and a passion for improving the patient journey.
Outside of work, she enjoys boating and water sports!
#RareDiseaseCare https://x.com/NSPharmaInc/status/1942238855966409099/photo/1
A warm welcome to Jon Yochum, our new National Account Director!
Jon joins us most recently from Sanofi, bringing with him over 20 years of experience in strategic account management across multiple therapeutic areas.
We're thrilled to have you, Jon!
#NewHire #Welcome https://x.com/NSPharmaInc/status/1940410321295835269/photo/1
We believe collaboration drives progress, so we are very proud to announce a new strategic alliance with @BostonChildrens Hospital to advance innovative therapies for rare diseases!
Read the press release: https://ow.ly/9RG050Wj6yV
#RareDiseases #Collaboration #PharmaInnovation https://x.com/NSPharmaInc/status/1940060975085789195/photo/1
